Latest Novartis Stories
bioCSL to take on expanded role in global influenza vaccine industry MELBOURNE, Australia, Oct.
He will lead all research and development for the firm’s algae proteins used in human pharmaceuticals and specialty animal feed products. San Diego, CA (PRWEB)
Through music and resources Our Voice in Song(TM) inspires people living with relapsing MS to become more active managers of their disease EAST HANOVER, N.J., Oct.
- Biologics License Application (BLA) for secukinumab, a "first-in-class" IL-17A inhibitor, is currently under FDA review with an anticipated action date in early 2015 EAST
SAN DIEGO, Oct. 20, 2014 /PRNewswire/ -- AnaptysBio, Inc., a leader in the discovery and development of therapeutic antibodies, today announced the appointment of Marco Londei, M.D.
BASEL, Switzerland, Oct.
- Preliminary study results show 27 of 30 pediatric and adult patients with relapsed/refractory (r/r) ALL (90%) experienced complete remissions with personalized cell therapy, CTL0191 EAST
LONDON, Oct. 9, 2014 /PRNewswire/ -- The global market for seed treatment in cotton is forecast to maintain the slowest 2014-2020 CAGR of 5.3% in comparison to other crop types.
LONDON, Oct. 9, 2014 /PRNewswire/ -- The global market for seed treatment in rice is likely to post a relatively modest CAGR of 6.1% during the 2014-2020 analysis period.
- A volcanic mudflow.